Want to see JP:7780 full AI Analyst Report?
7780 Stock Chart & Stats
¥1597.00
-¥6.00(-0.44%)
At close: 4:00 PM EST
¥1597.00
-¥6.00(-0.44%)
Day’s Range― - ―
52-Week Range¥1,090.00 - ¥2,086.00
Previous CloseN/A
Volume259.20K
Average Volume (3M)256.35K
Market Cap
¥144.80B
Enterprise Value¥171.31K
Total Cash (Recent Filing)¥34.07B
Total Debt (Recent Filing)¥81.55B
Price to Earnings (P/E)19.4
Beta0.72
Next Earnings
Nov 16, 2026EPS Estimate
23.85Next Dividend Ex-DateN/A
Dividend Yield1.5%
Share Statistics
EPS (TTM)96.34
Shares Outstanding76,771,484
10 Day Avg. Volume195,600
30 Day Avg. Volume256,346
Financial Highlights & Ratios
PEG Ratio3.13
Price to Book (P/B)1.34
Price to Sales (P/S)1.01
P/FCF Ratio-37.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥2,400.00Price Target Upside50.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)94.58
Revenue Forecast (FY)¥132.79B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthThe sustained increase in revenue indicates continued demand for Menicon’s contact lenses and eye-care products. Although growth has slowed recently, the multi-year expansion supports a durable business model and established market reach.
Strong Gross MarginsStable gross margins suggest Menicon retains attractive product economics and some ability to defend value across its vision-care portfolio. This provides a foundation for funding operations and supporting profitability despite pressure below the gross-profit line.
Growing Equity BaseThe expanding equity base strengthens Menicon’s balance-sheet foundation and provides greater capacity to absorb operating volatility or fund investment. This supports long-term resilience, even though rising debt has reduced some of that financial flexibility.
Bears Say
Persistent Negative Free Cash FlowRecurring negative free cash flow indicates that investment requirements or working-capital needs are absorbing operating cash. If sustained, this can limit internally funded growth, increase reliance on financing, and reduce resilience during weaker operating periods.
Higher LeverageHigher leverage reduces financial flexibility and increases the claims on future cash generation. With free cash flow already weak, the elevated debt burden could constrain investment choices and make the company more sensitive to earnings or operating setbacks.
Compressed ProfitabilityProfitability has weakened despite strong gross margins, indicating rising pressure from operating or other costs. Lower net margins and ROE reduce the efficiency of the business and may limit the cash available to support growth, debt reduction, and shareholder returns.
Menicon Co News
7780 FAQ
What was Menicon Co Ltd’s price range in the past 12 months?
Menicon Co Ltd lowest stock price was ¥1090.00 and its highest was ¥2086.00 in the past 12 months.
What is Menicon Co Ltd’s market cap?
Menicon Co Ltd’s market cap is ¥144.80B.
When is Menicon Co Ltd’s upcoming earnings report date?
Menicon Co Ltd’s upcoming earnings report date is Nov 16, 2026 which is in 72 days.
How were Menicon Co Ltd’s earnings last quarter?
Menicon Co Ltd released its earnings results on Aug 07, 2026. The company reported ¥30.05 earnings per share for the quarter, beating the consensus estimate of ¥16 by ¥14.05.
Is Menicon Co Ltd overvalued?
According to Wall Street analysts Menicon Co Ltd’s price is currently Undervalued.
Does Menicon Co Ltd pay dividends?
Menicon Co Ltd pays a Annually dividend of ¥28 which represents an annual dividend yield of 1.5%. See more information on Menicon Co Ltd dividends here
What is Menicon Co Ltd’s EPS estimate?
Menicon Co Ltd’s EPS estimate is 23.85.
How many shares outstanding does Menicon Co Ltd have?
Menicon Co Ltd has 76,771,484 shares outstanding.
What happened to Menicon Co Ltd’s price movement after its last earnings report?
Menicon Co Ltd reported an EPS of ¥30.05 in its last earnings report, beating expectations of ¥16. Following the earnings report the stock price went up 14.931%.
Which hedge fund is a major shareholder of Menicon Co Ltd?
Currently, no hedge funds are holding shares in JP:7780
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Menicon Co Ltd
Menicon Co., Ltd. (7780) is a Japan-based medical device company focused on vision care. It develops, manufactures, and sells contact lenses and related eye-care products, and is also involved in ophthalmic solutions and associated services supporting contact lens use.
7780 Stock 12 Month Forecast
Average Price Target
¥2,400.00
▲(50.28% Upside)
Technical Analysis
HOYA
―
JINS HOLDINGS
―
Japan Eyewear Holdings Co.,Ltd.
―
Mani, Inc.
―
Seed Co., Ltd.
―









